🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The purpose of this study in healthy toddlers who have not previously been ...
Status
Completed
Location
Werderstrasse 3
Start Date
2008-03
Trial ID
NCT00617760
The goal of the research proposed in the current application is to first de...
Status
Terminated
Location
Ralph H. Johnson VA Medical Center, Charleston, SC
Start Date
2018-11-01
Trial ID
NCT03802994
To determine the immunogenicity of Prevenar in infants immunized at 2, 4 an...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00276107
Treatments Being Tested
Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Status
Completed
Location
Neihuang Center for Disease Control and Prevention
Start Date
2021-04-13
Trial ID
NCT04841369
Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Status
Completed
Location
Neihuang Center for Disease Control and Prevention
Start Date
2020-05-18
Trial ID
NCT04100772
This study is a combination of a Phase I and Phase III study design. The Ph...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00488826
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested